Edition:
United Kingdom

People: Piramal Enterprises Ltd (PIRA.NS)

PIRA.NS on National Stock Exchange of India

1,724.50INR
22 Aug 2019
Change (% chg)

-- (--)
Prev Close
Rs1,724.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,059,340
52-wk High
Rs3,307.95
52-wk Low
Rs1,652.35

Piramal, Nandini 

Ms. Nandini Piramal is Executive Director of Piramal Enterprises Limited. She leads the Over-The-Counter (OTC) business of the Company. She heads the Human Resources function at Piramal Group and the Quality & Risk functions at Piramal Enterprises. Over the last five years, under Nandini’s leadership, the Company’s OTC segment has become one of the fastest-growing Indian OTC businesses. All our brands are either no.1 or no.2 in their respective categories. She has played a pivotal role in Piramal Healthcare’s branded generic-medicine business sale to Abbott Laboratories at a record 30x EBITDA. She has recently initiated an HR transformation strategy, with renewed focus on service delivery, customer centricity and operational excellence. This is a five-year restructuring programme, SEEDS, to build and develop the existing talent and to attract new talent. In 2014, the World Economic Forum recognised Nandini as a ‘Young Global Leader’. Nandini is passionately involved with Piramal Foundation, the philanthropic arm of Piramal Group. She directs implementation strategy across Piramal Foundation Education Leadership programmes, Piramal Sarvajal and Piramal Swasthya. She graduated with BA (Hons) Politics, Philosophy, and Economics from Oxford University, followed by an MBA from Stanford Graduate School of Business.

Basic Compensation

Total Annual Compensation, INR 37,847,900
Restricted Stock Award, INR --
Long-Term Incentive Plans, INR --
All Other, INR 39,600
Fiscal Year Total, INR 37,887,500

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Ajay Piramal

112,489,000

Swati Piramal

50,451,400

Vivek Valsaraj

14,642,000

Peter DeYoung

--

Jonathan Sandler

--

Vivek Sharma

--
As Of  31 Mar 2018